Journal News

Move over, DNA. The future is protein

Renae   Crossing
Sept. 20, 2022

In the coming decades, efforts to understand disease will be propelled by building 3D maps of protein arrangements in cells over time, a team of scientists says.

A workshop about the study of proteins on a large scale — proteomics — yielded a perspective piece that is part vision, part plan, recently published in the journal Molecular & Cellular Proteomics.

DNA is like a game plan, explains Neil Kelleher, a researcher at Northwestern University who was involved in the study, and RNA is like the team huddle; it’s what the cell decides to do with the circumstances on the day.

It’s time to watch the game itself. “This is the decade,” Kelleher said.

Maps will show how proteins take different forms over space and time, from milliseconds to years. It’s postgame analysis for cells.
Neil Kelleher et al./MCP
Maps will show how proteins take different forms over space and time, from milliseconds to years. It’s postgame analysis for cells.

Watching the game

“Traditionally, we study one protein or pathway at a time,” the authors write, because “the cell is otherwise too complex.”

That’s like watching one player over time and whom they pass to.

Proteins take multiple forms in a cell after they come off the bench. An electric link between fans and footballers inspires the play that decides a championship. A comment or word from a coach flicks a switch. In the cell, such switches can be as simple as a few atoms added (phosphorus and a trio of oxygens are a popular one). Altered by their circumstances, proteins are like people.

Mapping their shapes over time will be game-changing.

“This could impact all diseases,” said Kristin Burnum–Johnson of Pacific Northwest National Laboratory, first author of the paper.

How will this happen?

Bottoms up, touchdowns

Scientists will tackle this from two directions: bottom-up and top-down. They start with clinical tissue samples, Burnum–Johnson explained.

"For bottom-up approaches, you extract proteins from tissue regions and break them into identifiable peptides (shorter strings of proteins).”

Bottom-up strategies, combined with RNA and metabolite data, will reveal the lineup. Top-down strategies will yield those sweet, sweet action shots.

Kelleher knows about this. The top-down approach, revealing the specific forms proteins take (which RNA sequencing can’t tell you), has become so sensitive that his research recently found 30,000 precise forms of proteins in blood and bone marrow alone. That’s almost 10 times more than in previous studies. There are thousands more cell types for postgame analysis.

Single-minded

Researchers will continue pushing for higher resolution. They’ll need to integrate data, which is not a simple challenge. They’ll need to think beyond stadium walls; the extracellular matrix is rich. Like football and cells alike, consortiums and partnerships will drive the process. The National Institutes of Health wants research gaps to be identified, and private investment is supporting the sequencing of single molecules. These combined efforts remind Kelleher of the Human Genome Project.

The central dogma of biology is DNA to RNA to protein. It’s only natural that scientific research follows the path that is familiar. It’s protein’s turn.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Renae   Crossing

Renae Crossing is a writer and former teacher. She holds a first-class master’s degree in life science from the Hong Kong University of Science and Technology and a first-class master’s in teaching from the University of Melbourne.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

From the JBC archives: Madness, indoles and mercury-based cathartics
Journal of Biological Chemistry

From the JBC archives: Madness, indoles and mercury-based cathartics

Feb. 11, 2025

A 1907 paper sought to resolve an ongoing question of whether indole, a bacterial molecule in the gut, could cause insanity if overproduced.

From the journals: JBC
Journal News

From the journals: JBC

Feb. 7, 2025

Linking modified cysteines to cell migration. Recognizing protein tags for degradation. Disrupting C. difficile toxin production. Read about recent JBC papers on these topics.

Becoming a scientific honey bee
Essay

Becoming a scientific honey bee

Feb. 5, 2025

At the World Science Forum, a speaker’s call for scientists to go out and “make honey” felt like the answer to a question Katy Brewer had been considering for a long time.

Mutant RNA exosome protein linked to neurodevelopmental defects
Journal News

Mutant RNA exosome protein linked to neurodevelopmental defects

Feb. 4, 2025

Researchers at Emory University find that a missense mutation impairs RNA exosome assembly and translation and causes neurological disease.

Study sheds light on treatment for rare genetic disorder
News

Study sheds light on treatment for rare genetic disorder

Feb. 2, 2025

Aaron Hoskins’ lab partnered with a drug company to understand how RNA-targeting drugs work on spinal muscular atrophy, a disorder resulting from errors in production of a protein related to muscle movement.

Examining mechanisms of protein complex at a basic cell biological level
News

Examining mechanisms of protein complex at a basic cell biological level

Feb. 1, 2025

Mary Munson is co-corresponding author on a study revealing functions and mechanisms of the exocyst that are essential to how molecules move across a membrane through vesicles in a cell.